Shook Hardy Bacon Shook Hardy Bacon Menu

Results

Success fosters insight; insight informs success. Our representative matters look beyond the immediate solution to the next challenge facing your business and industry.

Of course, past outcomes afford no guarantee of future results. Every case is different and must be judged on its own merits.

Filter By:
View:
Success | Pharmaceutical and Medical Device

U.S. Supreme Court Denies Cert to Mirena MDL Plaintiffs

The U.S. Supreme Court has denied a petition for writ of certiorari filed by plaintiffs in the Mirena® multidistrict litigation, effectively ending litigation in federal courts that involved more than 1,300 plaintiffs and lasted more than five years.

Success | Pharmaceutical and Medical Device

Shook Team Obtains Third Win This Year for Pharmacia

A Shook team has obtained their third win in a year for Pharmacia & Upjohn Co. LLC (Pharmacia), the maker of the corticosteroid drug Depo-Medrol® (methylprednisone acetate).

Success | Pharmaceutical and Medical Device

Shook Obtains Back-to-Back Wins for Medtronic In Product Liability Cases

Shook teams have obtained back-to-back wins for Medtronic, manufacturer of surgical and medical devices, persuading federal courts in Michigan and Texas to dismiss product liability claims against the company.
Success | Pharmaceutical and Medical Device

Eleventh Circuit Affirms Summary Judgment for Marketers of Enbrel

The Eleventh Circuit has affirmed a lower court’s grant of summary judgment in favor of the makers and marketers of the biologic drug Enbrel, finding that the plaintiffs' injury claims were barred by the learned intermediary doctrine and that the direct “patient labeling requirement” in FDA medication guidelines did not preempt application of the doctrine. 

Success | Pharmaceutical and Medical Device

Second Circuit Affirms Dismissal of Mirena MDL

The U.S. Court of Appeals for the Second Circuit has affirmed the dismissal of litigation in which plaintiffs sought recovery for injuries they alleged were caused by Bayer’s intrauterine contraceptive system, Mirena®.  Nearly 1,300 cases were certified as part of an MDL in 2013; the U.S. District Court for the Southern District of New York dismissed the cases in July 2016.